.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In August 2026, Green Mantis Labs operated a single-category portfolio, with Tincture & Sublingual accounting for 100.0% of sales and a month-over-month decline of 27.8%. Within New York Tincture & Sublingual, the brand held rank 11, indicating a mid-pack position despite the concentrated mix at 100.0%. With an average price of $42.16 alongside a 27.8% MoM contraction and no offsetting categories to buffer volatility, the pattern implies concentration risk: single-category exposure amplifies swings and ties performance tightly to Tincture & Sublingual demand cycles.
The 100.0% reliance on Tincture & Sublingual combined with rank 11 in New York suggests positioning as a niche, category-focused player rather than a diversified competitor, and the 27.8% MoM pullback signals sensitivity to monthly shifts in Tincture & Sublingual traffic. Given that the brand lacks share from adjacent form factors (0.0% outside Tincture & Sublingual) while sitting outside the top 10 at rank 11, the implication is that incremental gains will likely come from either price-pack architecture within Tincture & Sublingual or expansion into a second category to dilute the 100.0% exposure.
Competitive Landscape
Green Mantis Labs sits at rank 11 in New York Tincture & Sublingual for August 2026, up 1 position from rank 12 in May 2026, while remaining 2 spots below its peak rank of 9 reached in July 2026; this places it 10 positions behind Ayrloom at rank 1 and 9 spots behind Head & Heal at rank 2, with Ayrloom holding rank 1 year over year and Head & Heal steady at rank 2 despite a -24.7% sales YoY change. Over the last three months, Green Mantis Labs improved 1 rank (from 12 to 11) while OMO - Open Minded Organics advanced from rank 6 to rank 5 and posted a -26.4% sales YoY change, indicating Green Mantis Labs is gaining rank via consistency rather than outsized YoY spikes; the trajectory implies a gradual climb is plausible if it sustains position gains against competitors with flat or negative YoY trends.
Notable Products
CBN/THC 2:1 Sleep Blueberry Tincture (400mg CBN, 200mg THC) posted the steepest decline in August 2026 at -65.5% and slid to rank 4, while CBN/THC 1:2 Sleep Blueberry Tincture (300mg CBN, 600mg THC) fell -52.7% to rank 3. In contrast, Watermelon Tincture (1000mg THC, 60ml) rose +5.9% and held rank 2 as CBD/THC 1:1 Citrus Tincture (1000mg CBD, 1000mg THC) dropped -36.8% yet remained rank 1 with $10,539 in sales. With four of the top ten positions occupied by Tincture & Sublingual SKUs and two sleep-focused CBN products contracting more than -50%, the mix points to a pivot away from sleep formulations toward core THC-forward tinctures for Green Mantis Labs.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
